These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2157897)

  • 21. Linker scan analysis of the early regulatory region of human papovavirus BK.
    Deyerle KL; Subramani S
    J Virol; 1988 Sep; 62(9):3378-87. PubMed ID: 2841491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The spliced structure of BK virus mRNAs in lytically infected and transormed cells.
    Manaker RA; Khoury G; Lai CJ
    Virology; 1979 Aug; 97(1):112-21. PubMed ID: 224572
    [No Abstract]   [Full Text] [Related]  

  • 23. Polyomavirus genome and polyomavirus enhancer-driven gene expression during myogenesis.
    Maione R; Felsani A; Pozzi L; Caruso M; Amati P
    J Virol; 1989 Nov; 63(11):4890-7. PubMed ID: 2552161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The early enhancer-promoter of BKV and host range for transformation.
    de Ronde A; MacDonald M; Sol C; ter Schegget J; Wouters E; van Strien A; van der Noordaa J
    Intervirology; 1987; 27(1):38-44. PubMed ID: 3038777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions.
    Markowitz RB; Eaton BA; Kubik MF; Latorra D; McGregor JA; Dynan WS
    J Virol; 1991 Aug; 65(8):4515-9. PubMed ID: 1649346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A naturally occurring deletion in the enhancer repeats of the human papovavirus BK optimizes early enhancer function at the expense of late promoter activity.
    Cassill JA; Subramani S
    Virology; 1989 May; 170(1):296-8. PubMed ID: 2541546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion analysis of the polyomavirus late promoter: evidence for both positive and negative elements in the absence of early proteins.
    Cahill KB; Carmichael GG
    J Virol; 1989 Sep; 63(9):3634-42. PubMed ID: 2547989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repression by Jun of the Polyoma-virus enhancer overrides activation in a cell specific manner.
    Schneikert J; Imler JL; Wasylyk B
    Nucleic Acids Res; 1991 Feb; 19(4):783-7. PubMed ID: 1850124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concerted expression of BK virus large T- and small t-antigens strongly enhances oestrogen receptor-mediated transcription.
    Moens U; Van Ghelue M; Johansen B; Seternes OM
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():585-594. PubMed ID: 10091996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of early-response genes during polyomavirus infection.
    Glenn GM; Eckhart W
    J Virol; 1990 May; 64(5):2193-201. PubMed ID: 1691311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteins of the nuclear factor-1 family act as an activator of the late promoter in human polyomavirus BK in vitro.
    Chakraborty T; Das GC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1935-42. PubMed ID: 1651986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polyomavirus enhancer-binding protein, PEBP5, responsive to 12-O-tetradecanoylphorbol-13-acetate but distinct from AP-1.
    Asano M; Murakami Y; Furukawa K; Yamaguchi-Iwai Y; Satake M; Ito Y
    J Virol; 1990 Dec; 64(12):5927-38. PubMed ID: 2173774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of human glutathione S-transferase pi gene transcription: influence of 5'-flanking sequences and trans-activating factors which recognize AP-1-binding sites.
    Morrow CS; Goldsmith ME; Cowan KH
    Gene; 1990 Apr; 88(2):215-25. PubMed ID: 2112105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites.
    Chan WK; Chong T; Bernard HU; Klock G
    Nucleic Acids Res; 1990 Feb; 18(4):763-9. PubMed ID: 2156229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An element of the BK virus enhancer required for DNA replication.
    Del Vecchio AM; Steinman RA; Ricciardi RP
    J Virol; 1989 Apr; 63(4):1514-24. PubMed ID: 2538642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
    Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
    Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A variant enhancer/regulatory region from a cloned human prototype BK virus genome.
    Berg DT; Walls JD; Grinnell BW
    Nucleic Acids Res; 1988 Sep; 16(18):9057. PubMed ID: 2845365
    [No Abstract]   [Full Text] [Related]  

  • 38. Nuclear factor 1 family members mediate repression of the BK virus late promoter.
    Kraus RJ; Shadley L; Mertz JE
    Virology; 2001 Aug; 287(1):89-104. PubMed ID: 11504545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A liver-specific enhancer in the core promoter region of human hepatitis B virus.
    Yee JK
    Science; 1989 Nov; 246(4930):658-61. PubMed ID: 2554495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
    Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
    New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.